Genetic Engineering News: Breaking Genetic Engineering News, Comments and Articles.

16:01 EDT 27th May 2015 | BioPortfolio

Genetic Engineering NewsRSS

Read the latest Genetic Engineering News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Genetic Engineering.

Search or Follow Our Genetic Engineering News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Genetic Engineering News.

Showing "genetic engineering genetics" News Articles 1 to 25 of 7,400+

Wednesday 27th May 2015

La Jolla Pharmaceutical Company to Provide Corporate Overview at the Jefferies 2015 Global Healthcare Conference

La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that George F. Tidmarsh, M.D., Ph.D., President and Chief Executive Officer of La Jolla, will provide a corporat...

Ignyta to Present at 2015 Jefferies Healthcare Conference

Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, announced today that Jonathan Lim., M.D., its Chairman and Chief Executive Officer, and Jacob Chacko, M.D., its Chief Financial Officer, will make a presentation at the 2015 Jefferies Healthcare Conference on June 3, 2015 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) in New York...

The Coalition of State Bioscience Institutes Announce the Winners of the 2015 STEM Voice Video Competition

The Coalition of State Bioscience Institutes (CSBI), a group of non-profits organized to advance education, entrepreneurship and STEM workforce development, announced the winners of the STEM Voice video competition in collaboration with MdBio Foundation (Rockville, MD,) EDUCATE Center of the iBIO Institute (Chicago, IL) and the Biocom Institute (San Diego ...

Anaheim Ducks Captain Ryan Getzlaf to Host 5th Annual Getzlaf Golf Shootout to Benefit Cure Duchenne

The 5th Annual Getzlaf Golf Shootout benefiting CureDuchenne will be held September 12 at Sutra Lounge in Costa Mesa, Calif. and September 13 at the Monarch Beach Golf Links in Dana Point, Calif. Hosted by

A Genetic Device to Degrade Targeted DNA in GMO Developed

Massachusetts Institute of Technology researchers, Brian J. Caliando and Christopher A. Voigt developed a genetically encoded device based on the CRISPR system, the DNAi, that has the ability to respond to transcriptional input and degrades specific DNA. This enables engineered regions to be concealed when the cell enters a new environment.In the C...

Sex Determining Genes in Mosquitoes Could Help Fight Dengue Fever

Researchers at the Fralin Life Science Institute at Virginia Tech have identified a gene responsible for sex determination in mosquitoes that transmit yellow fever, dengue, and chikungunya viruses. The researchers identified a male-determining genetic switch called Nix in Aedes aegypti mosquitoes that underlies the difference between males and fema...

Screening Genetic Defects in Domestic Livestock Tackled in NAST PHL Roundtable Discussion

The importance of genetic markers and genome mapping as tools in domestic animal breeds were highlighted and elaborated on during the roundtable discussion on Screening Genetic Defects in Domestic Livestock Industry organized by the National Academy of Science and Technology Philippines (NAST PHL) on May 14, 2015 at Acacia Hotel, Manila. The activi...

Akron Biotech and Cognate BioServices Announce Strategic Partnership

Cognate BioServices, Inc. and Akron Biotechnology, LLC are pleased to announce a strategic partnership that brings two industry leaders together to provide a more complete package of services to their clients. Cognate is a leader in the provision of cGMP manufacturing services and regulatory support to companies and institutions engaged in the development ...

Scientists Tout New ‘Rosetta Stone’ for Prostate Cancer Mutations

About 90 percent of advanced prostate cancers have particular genetic mutations that can provide a target for cancer drugs.Read more about Scientists Tout New ‘Rosetta Stone’ for Prostate Cancer Mutations

Creative Diagnostics Reinforces Hi-affinity™ Bacterial Display Platform to Better Produce Therapeutic Antibodies

New York, NY, May 27, 2015 --(PR.com)-- In earlier time, Creative Diagnostics together with Creative Biolabs developed a unique bacterial display technology, Hi-affinityTM, for the development of human antibodies with pM affinity, intended for research, diagnostic and therapeutic use. “With the emerging of this technology, an in vitro antibody production technology with highest affinity is...

Arizona Oncology Now Offering Palliative Care for Patients in Tucson

Arizona Oncology, a leader in community based cancer care and a practice in The US Oncology Network, is now offering palliative care to patients in Tucson and

FDA Accepts BPL’s Amended BLA Submission for Coagadex® (Coagulation Factor X, Human)

Bio Products Laboratory, Ltd. (BPL), a leading manufacturer of plasma-derived therapies, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s amended Biologics License Application for Coagadex® for hereditary factor X deficiency. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal date of ...

Health Highlights: May 27, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: White House Puts Hold on Type of Gene Engineering Genetic engineering that makes DNA changes that are passed along to future generations should...

In-Depth Look at History’s Largest Genetic Twin Study

The largest meta-study of twins in history—which examines 14.5 million sets of twins — found that, generally, genes and environment play an equal role in human development.Read more about In-Depth

SmarterSkin Dermatology is Now Offering Skin DNA Analysis

The unique skin DNA analysis for customized skin care is now available in NYC. (PRWEB) May 27, 2015 SmarterSkin, http://www.smarterskindermatology.com, is taking skin care customization to a new level with a cutting-edge test that makes it easier for patients to find skin care products that work specifically for their skin type. Dr. Sejal Shah is a cosmetic dermatologist based in New York and is...

Fluidigm Brings Automated Targeted Library Prep to Juno

Fluidigm Corporation (NASDAQ:FLDM) will disclose details of its new automated library preparation application for targeted sequencing, optimized for its JunoTM system, at the upcoming European Human Genetics Conference in Glasgow, Scotland, June 6-9. The new library preparation application will expand genomic coverage capacity by an order of magnitude over...

Triton Technology Fund Announces Their Seed Round Investment in MANTA Instruments (MANTA)

Triton Technology Fund (TTF) announces their seed round investment in MANTA Instruments (MANTA), a seed stage technology company with breakthrough technology for characterizing nanoparticles. Funds from the seed round are enabling MANTA to accelerate commercialization of scientific instruments that measure nanoparticles more effectively than any c...

Congressional Action Needed To Optimize Regulation Of Genomic Tests

HOUSTON and SEATTLE, May 27, 2015 /PRNewswire-USNewswire/ -- The latest generation of genomic testing offers a chance for significant improvements in patient care, disease prevention, and possibly even the cost-effectiveness of healthcare, but Congress needs to act to incentivize the development of the massive data systems that doctors and regulators will need in order to make these tests safe and...

ASCO: Many cancer patients interested in genetic profiling

(HealthDay)—Many patients with cancer are interested in comprehensive tumor genetic profiling (CGP), and most are willing to pay out-of-pocket costs for CGP, according to a study scheduled for presentation at the annual meeting of the American Soci...

OTSUKA'S JINARC THE FIRST-EVER TREATMENT APPROVED IN EUROPE FOR ADULTS LIVING WITH ADPKD, A CHRONIC GENETIC KIDNEY DISEASE

JINARC (tolvaptan) is the first approved pharmaceutical therapy available in Europe for patients with autosomal dominant polycystic kidney disease (ADPKD) that targets the underlying pathophysiolo...

Origin of chromosomal oddity in some cancer cells identified

Surveys of the genomic terrain of cancer have turned up a curious phenomenon in some tumor cells: a massive rearrangement of DNA in one or a few chromosomes, thought to be produced during a single cell cycle. In a new study, scientists at Dana-Farber...

Researchers oppose unvalidated gene panel tests for cancer links

CHICAGO, May 27 (Reuters) - A group of international researchers is making the case that genetic tests that look for multiple hereditary genes suspected of being linked to breast cancer should not be offered until they are proven to be valid and usef...

Infinity to Participate in Three Investor Conferences in June

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the following three upcoming conferences: Jefferies Global Healthcare Conference, New York, June 3rd , at 4:30 p.m. ET William Blair Growth Stock Conference, Chicago, June 9th, at 8:50 a.m. CT (9:50 a.m. ET) JMP Securities 2015 ...

Beryllium Develops an MCL-1 Platform for Structure-Guided Drug Discovery in Collaboration with the Broad Institute

Research details are published in a recent issue of PLOS One Beryllium, a scientific research services company engaging in collaborations with commercial and academic partners, today announced the development of an MCL-1 platform for structure-guided drug discovery. MCL-1 is one of the top-ten most amplified genes in all of human cancer and is vital to...

Calimmune Completes $15 Million Series B Financing

Proceeds Will Advance Clinical Trials for Gene-Based HIV/AIDS Therapies Calimmune Inc., a clinical-stage gene therapy company, has successfully completed its $15 million Series B financing round, led by a large pharmaceutical company. Alexandria Venture Investments also joined with existing investors including RA Capital Healthcare Fund LP and T...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks